Top Tweets for #mtc26

7 days ago

A closing idea worth keeping from #MTC26: performance only creates value when it changes care. For us that is the whole point of the work, a result only matters if it reaches the patients it is meant to help. #MedTech

SonaNanotech's tweet photo. A closing idea worth keeping from #MTC26: performance only creates value when it changes care. For us that is the whole point of the work, a result only matters if it reaches the patients it is meant to help. #MedTech https://t.co/HbQXLmgO1S

1

7

0

290

David Regan

@DavidReganSona

7 days ago

Leaving #MTC26 with one idea I keep coming back to, from a talk on value translation: performance only creates value when it changes care. A result on a slide means nothing until it changes what happens to a patient. That is the bar we try to hold ourselves to. #MedTech

DavidReganSona's tweet photo. Leaving #MTC26 with one idea I keep coming back to, from a talk on value translation: performance only creates value when it changes care. A result on a slide means nothing until it changes what happens to a patient. That is the bar we try to hold ourselves to.

#MedTech https://t.co/UMdckQK0Zq

0

1

0

4

Jack Kalavritinos

@Jkal1985

7 days ago

That’s a wrap Four days at #MTC26 A few more highlights 🔹FDA leaders here in force - MDUFA 6 and AI 🔹M&A’s medtech secret sauce 🔹Dark money funding mass lawsuits, is help on the way? @AdvaMedUpdate @FDA @FDADevices @sullcrom @Philips @SHBLaw @RealClearHealth @jk_strat @WHICINNOVATES

0

3

0

103

FYELABS @fyelabs

7 days ago

🙌A pleasure to welcome Tyler Allsopp, Parliamentary Assistant to Ontario’s Minister of Economic Development, Job Creation and Trade, to @FYELABS Booth 1111 at #MTC26 in Boston! Jit and Thierry also welcomed new friend Tamara Bush, Co-Founder of Sit Sense, at @MedTechCon.

fyelabs's tweet photo. 🙌A pleasure to welcome Tyler Allsopp, Parliamentary Assistant to Ontario’s Minister of Economic Development, Job Creation and Trade, to @FYELABS Booth 1111 at #MTC26 in Boston!

Jit and Thierry also welcomed new friend Tamara Bush, Co-Founder of Sit Sense, at @MedTechCon. https://t.co/r8081AgkcQ

0

21

7 days ago

Nicely done @FDA this is going in the right direction #mtc26

0

3

0

236

8 days ago

@ScottWMedTech thank you for your leadership and all you do for our great industry. This year's conference has been the best ever. The future looks bright as long as people like us keep pushing the industry forward and leading from the front #mtc26

OmarMKhateeb's tweet photo. @ScottWMedTech thank you for your leadership and all you do for our great industry. This year's conference has been the best ever. The future looks bright as long as people like us keep pushing the industry forward and leading from the front #mtc26 https://t.co/v6aduifLHS

0

3

0

183

Ritu Thamman MD

@iamritu

9 days ago

Panel of point of care innovation #echofirst #telemedNow with @ButterflyNetInc Joe & @MIT Elazer Edelman & Karl Dauphinais #MTC26

iamritu's tweet photo. Panel of point of care innovation #echofirst #telemedNow with @ButterflyNetInc Joe & @MIT Elazer Edelman & Karl Dauphinais #MTC26 https://t.co/l7VeUXkEHc

4

21

3

0

2K

9 days ago

The medtech industry is increasingly focused on access, getting proven technology to the patients who need it. For a company built to widen who immunotherapy can help, that focus is home turf. #MTC26 @MedTechCon, @AdvaMedUpdate #MedTechCon

SonaNanotech's tweet photo. The medtech industry is increasingly focused on access, getting proven technology to the patients who need it. For a company built to widen who immunotherapy can help, that focus is home turf. #MTC26

@MedTechCon, @AdvaMedUpdate #MedTechCon https://t.co/mPu7BKgtvq

0

6

1

296

9 days ago

@AdvaMedUpdate President @ScottWMedTech had a great keynote to kick off #mtc26 He hit on the fact that in Washington the debate always starts with “What does this device cost?” The first question should be: What is a human life worth? MedTech is not a cost driver. It’s a cost saver. It finds disease before it becomes a crisis. It gets patients out of the hospital faster. It keeps people independent and productive. Some examples: - Catheter-based heart valve replacements instead of open-chest surgery -Joint replacements that restore walking, work, and time with grandkids -AI-assisted mammography → 99% 5-year survival when breast cancer is caught early MedTech is still <6% of healthcare spending and has grown more slowly than overall costs while investing $20B+ a year in R&D. Scott shared The MedTech multiplier: one life changed ripples to family, workplace, and community. 1 + 1 = 1,000. The shift we need is to stop asking only “What does this technology cost today?” and start asking “What spending does it prevent tomorrow and what does it make possible?” That’s the value of MedTech. #mtc26

OmarMKhateeb's tweet photo. @AdvaMedUpdate President @ScottWMedTech had a great keynote to kick off #mtc26

He hit on the fact that in Washington the debate always starts with “What does this device cost?”

The first question should be: What is a human life worth?

MedTech is not a cost driver. It’s a cost saver.

It finds disease before it becomes a crisis. It gets patients out of the hospital faster. It keeps people independent and productive.

Some examples:
- Catheter-based heart valve replacements instead of open-chest surgery

-Joint replacements that restore walking, work, and time with grandkids

-AI-assisted mammography → 99% 5-year survival when breast cancer is caught early

MedTech is still <6% of healthcare spending and has grown more slowly than overall costs while investing $20B+ a year in R&D.

Scott shared The MedTech multiplier: one life changed ripples to family, workplace, and community. 1 + 1 = 1,000.

The shift we need is to stop asking only “What does this technology cost today?” and start asking “What spending does it prevent tomorrow and what does it make possible?”

That’s the value of MedTech. #mtc26

1

5

0

243

9 days ago

Why we are here: Targeted Hyperthermia Therapy is designed to prime tumors so immunotherapy works for more people. Device-enabled, biology-driven. #MTC26 @MedTechCon, @AdvaMedUpdate #MedTechCon

SonaNanotech's tweet photo. Why we are here: Targeted Hyperthermia Therapy is designed to prime tumors so immunotherapy works for more people. Device-enabled, biology-driven. #MTC26

@MedTechCon, @AdvaMedUpdate #MedTechCon https://t.co/mIlpHPKRba

0

11

2

1

567

9 days ago

Day 1 of #MTC26 @MedTechCon 🚀🚀

0

5

1

0

233

9 days ago

Great session at #MTC26 @iRhythmTech CEO Quentin Blackford had a great point on medtech and tech. The winners in our space will own Clinical accountability but that we have to find ways to do partnerships with big tech to amplify the value we deliver to patients.

OmarMKhateeb's tweet photo. Great session at #MTC26 @iRhythmTech CEO Quentin Blackford had a great point on medtech and tech. The winners in our space will own Clinical accountability but that we have to find ways to do partnerships with big tech to amplify the value we deliver to patients. https://t.co/jNJrDSGWrL

0

3

2

0

275

9 days ago

Day two at #MTC26 in Boston. Thousands of medtech leaders, one shared question: how do we get better technology to more patients, faster? That is the room Sona wants to be in. @MedTechCon, @AdvaMedUpdate #MedTechCon

SonaNanotech's tweet photo. Day two at #MTC26 in Boston. Thousands of medtech leaders, one shared question: how do we get better technology to more patients, faster? That is the room Sona wants to be in.

@MedTechCon, @AdvaMedUpdate #MedTechCon https://t.co/BToAoDIgaS

0

8

0

1

296

10 days ago

What we are watching at #MTC26: the convergence of devices and immuno-oncology. Local, precisely delivered approaches that change how a tumor behaves, so the immune system and existing drugs can do more. The field is moving toward the tumor, not just the bloodstream. #MedTech #Immunotherapy

SonaNanotech's tweet photo. What we are watching at #MTC26: the convergence of devices and immuno-oncology. Local, precisely delivered approaches that change how a tumor behaves, so the immune system and existing drugs can do more. The field is moving toward the tumor, not just the bloodstream.

#MedTech #Immunotherapy

1

11

1

0

231

12 days ago

Heading to #MTC26 in Boston over the weekend. One theme we are watching: getting proven technology to the patients it currently misses. That gap is the reason Sona exists. #MedTech

SonaNanotech's tweet photo. Heading to #MTC26 in Boston over the weekend. One theme we are watching: getting proven technology to the patients it currently misses. That gap is the reason Sona exists.

#MedTech https://t.co/EKvH9kUXUP

0

8

2

0

361